Montelukast BE study - Cmax shows supra bioavailability [Regulatives / Guidelines]

posted by ElMaestro  – Denmark, 2016-12-01 15:50 (3033 d 23:10 ago) – Posting: # 16821
Views: 10,071

Hi Elam,

I am hearing you ask something like "Why is a system that divides all the world's synthetic drugs into four simple categories based on permeability and solubility not a predictor of my in vivo outcome?"
It is in my opinion the wrong question to ask.
We haven't even understood too well why BCS sometimes is a predictor.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,409 posts in 4,921 threads, 1,669 registered users;
17 visitors (0 registered, 17 guests [including 6 identified bots]).
Forum time: 15:00 CET (Europe/Vienna)

An expert is one who knows more and more
about less and less.    Nicholas Murray Butler

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5